$102.37
-0.85%Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and other brand names. The Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. The company sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to manufacturing, lodging, office building, food service, and public facilities, as well as through distributors and e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.
Warning: Liquidity concerns. Current assets may not be sufficient to cover short-term obligations.
High financial leverage. Heavy reliance on debt may indicate increased financial risk and potential solvency concerns.
Negative working capital indicates short-term liabilities exceed short-term assetsโpotential liquidity stress.
Capital-intensive business with significant long-term investments in property, equipment, or intangibles.
Financial stress indicators: Both liquidity and leverage metrics raise concerns. The company may face challenges meeting obligations and should focus on strengthening its balance sheet.
KMB โข NYSE
| Kimberly-Clark Corporation Balance Sheet | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | Dec 2007 | Dec 2006 | Dec 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ASSETS | ||||||||||||||||||||
CURRENT ASSETS | ||||||||||||||||||||
1B | 1.1B | 427M | 270M | 303M | 442M | 539M | 616M | 923M | 619M | 789M | 1.1B | 1.1B | 764M | 876M | 987M | 364M | 472.7M | 360.8M | 364M | |
1B | 1.1B | 427M | 270M | 303M | 442M | 539M | 616M | 923M | 619M | 789M | 1.1B | 1.1B | 764M | 876M | 987M | 364M | 472.7M | 360.8M | 364M | |
2B | 2.1B | 2.3B | 2.2B | 2.2B | 2.3B | 2.2B | 2.3B | 2.2B | 2.3B | 2.2B | 2.5B | 2.6B | 2.6B | 2.7B | 2.6B | 2.5B | 2.6B | 2.3B | 2.1B | |
1.9B | 2B | 2.1B | 2B | 2.1B | 2.1B | 2B | 2.1B | 2B | 2B | 2B | 2.3B | 2.3B | 2.3B | 2.5B | 2.6B | 2.5B | 2.6B | 2.3B | 2.1B | |
154M | 150M | 189M | 170M | 153M | 181M | 167M | 168M | 167M | 329M | 210M | 271M | 376M | 328M | 218M | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
1.8B | 2B | 2.3B | 2.2B | 1.9B | 1.8B | 1.8B | 1.8B | 1.7B | 1.9B | 1.9B | 2.2B | 2.3B | 2.4B | 2.4B | 2B | 2.5B | 2.4B | 2B | 1.8B | |
728M | 520M | 753M | 849M | 733M | 562M | 525M | 490M | 337M | 617M | 655M | 718M | 493M | 561M | 607M | 467M | 464M | 619.5M | 567.7M | 565.1M | |
5.6B | 5.7B | 5.7B | 5.6B | 5.2B | 5.1B | 5B | 5.2B | 5.1B | 5.4B | 5.6B | 6.6B | 6.6B | 6.3B | 6.3B | 5.9B | 5.8B | 6.1B | 5.3B | 4.8B | |
NON-CURRENT ASSETS | ||||||||||||||||||||
7.5B | 7.9B | 7.9B | 8.1B | 8B | 7.5B | 7.2B | 7.4B | 7.2B | 7.1B | 7.4B | 7.9B | 8.1B | 8B | 8.4B | 8B | 7.7B | 8.1B | 7.7B | 7.5B | |
2B | 2.1B | 2.1B | 1.8B | 1.9B | 1.5B | 1.5B | 1.6B | 1.5B | 1.4B | 1.6B | 3.2B | 3.3B | 3.3B | 3.4B | 3.3B | 2.7B | 2.9B | 2.9B | 2.7B | |
87M | 197M | 851M | 810M | 832M | 29M | 0.0 | 0.0 | 83M | 94M | 109M | 243M | 246M | 265M | 287M | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
2.1B | 2.3B | 2.9B | 2.7B | 2.7B | 1.5B | 1.5B | 1.6B | 1.6B | 1.5B | 1.7B | 3.4B | 3.6B | 3.6B | 3.7B | 3.3B | 2.7B | 2.9B | 2.9B | 2.7B | |
314M | 306M | 238M | 290M | 300M | 268M | 224M | 233M | 257M | 247M | 257M | 382M | 355M | 338M | 374M | 355M | 0.0 | 390M | 392.9M | 0.0 | |
1.1B | 1.1B | 1.2B | 1.2B | 1.3B | 1B | 620M | 695M | 581M | 525M | 614M | 615M | 1.3B | 1.1B | 1.1B | 1.4B | 1.9B | 1.3B | 1.3B | 1.3B | |
11B | 11.6B | 12.2B | 12.3B | 12.3B | 10.2B | 9.5B | 9.9B | 9.5B | 9.4B | 10B | 12.4B | 13.3B | 13.1B | 13.5B | 13.3B | 12.3B | 12.3B | 11.8B | 11.5B | |
16.5B | 17.3B | 18B | 17.8B | 17.5B | 15.3B | 14.5B | 15.2B | 14.6B | 14.8B | 15.5B | 18.9B | 19.9B | 19.4B | 19.9B | 19.2B | 18.1B | 18.4B | 17.1B | 16.3B | |
LIABILITIES | ||||||||||||||||||||
CURRENT LIABILITIES | ||||||||||||||||||||
4.4B | 4.3B | 4.5B | 4.5B | 4B | 3.6B | 3.8B | 3.4B | 3.2B | 3.3B | 3.3B | 3.2B | 3.1B | 2.9B | 2.6B | 2.2B | 1.4B | 1.4B | 1.2B | 1.4B | |
3.7B | 3.7B | 3.8B | 3.8B | 3.3B | 3.1B | 3.2B | 2.8B | 2.6B | 2.6B | 2.6B | 2.6B | 2.4B | 2.4B | 2.2B | 1.9B | 1.4B | 1.4B | 1.2B | 1.4B | |
690M | 688M | 706M | 703M | 691M | 583M | 605M | 590M | 588M | 647M | 640M | 645M | 625M | 543M | 373M | 329M | 0.0 | 0.0 | 0.0 | 0.0 | |
1.3B | 1.4B | 1.2B | 1.2B | 1.8B | 1.6B | 1.5B | 1.4B | 1.5B | 1.4B | 1.5B | 1.7B | 1.9B | 1.8B | 1.9B | 2.1B | 1.8B | 1.8B | 1.9B | 1.4B | |
552M | 567M | 844M | 433M | 486M | 1.5B | 1.2B | 953M | 1.1B | 1.7B | 1.3B | 375M | 1.1B | 706M | 344M | 610M | 1.1B | 1.1B | 1.3B | 1.2B | |
131M | 130M | 127M | 130M | 133M | 130M | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
288M | 294M | 318M | 323M | 332M | 231M | 260M | 249M | 259M | 329M | 330M | 336M | 336M | 266M | 104M | 79M | 0.0 | 0.0 | 0.0 | 0.0 | |
570M | 494M | 601M | 397M | 0.0 | 0.0 | 0.0 | 45M | 44M | 36M | 113M | 550M | 0.0 | 0.0 | 506M | 0.0 | 492M | 542.7M | 549.2M | 666.5M | |
7B | 6.9B | 7.3B | 6.7B | 6.4B | 6.9B | 6.5B | 5.9B | 5.8B | 6.3B | 6.2B | 5.8B | 6.1B | 5.4B | 5.7B | 4.9B | 4.8B | 4.9B | 5B | 4.6B | |
NON-CURRENT LIABILITIES | ||||||||||||||||||||
6.9B | 7.4B | 7.6B | 8.1B | 7.9B | 6.2B | 6.2B | 6.5B | 6.4B | 6.1B | 5.6B | 5.4B | 5.1B | 5.4B | 5.7B | 4.8B | 4.9B | 4.4B | 2.3B | 2.6B | |
326M | 374M | 647M | 694M | 723M | 511M | 458M | 395M | 532M | 766M | 587M | 817M | 0.0 | 0.0 | 629M | 377M | 193M | 369.7M | 391.1M | 572.9M | |
1B | 1.6B | 1.7B | 1.5B | 1.6B | 1.4B | 1.3B | 1.5B | 1.7B | 1.6B | 2.1B | 1.7B | 2.9B | 3B | 2.6B | 3.3B | 4B | 3B | 2.9B | 2.5B | |
8.6B | 9.3B | 9.9B | 10.4B | 10.2B | 8.2B | 8B | 8.4B | 8.6B | 8.5B | 8.3B | 7.9B | 8.5B | 8.4B | 8.3B | 8.6B | 9.1B | 7.8B | 5.5B | 5.7B | |
131M | 130M | 127M | 130M | 133M | 130M | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
15.6B | 16.3B | 17.3B | 17.1B | 16.7B | 15.1B | 14.6B | 14.3B | 14.5B | 14.8B | 14.5B | 13.8B | 14.6B | 13.8B | 13.7B | 13.5B | 13.8B | 12.7B | 10.5B | 10.4B | |
SHAREHOLDERS' EQUITY | ||||||||||||||||||||
-6B | -5.2B | -5.1B | -5.2B | -4.9B | -4.5B | -4B | -3.3B | -3.6B | -3B | -5.6B | -3.7B | -2.8B | -2.1B | -4.7B | -4.1B | -4.3B | -3.8B | -1.4B | -6.4B | |
0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 302M | 280M | 285M | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
473M | 473M | 473M | 473M | 473M | 473M | 473M | 473M | 473M | 473M | 536M | 536M | 536M | 536M | 598M | 598M | 598M | 598.3M | 598.3M | 710.8M | |
862M | 878M | 679M | 605M | 657M | 556M | 548M | 594M | 697M | 609M | 632M | 594M | 481M | 440M | 425M | 399M | 486M | 482.4M | 427.6M | 324.6M | |
9.3B | 8.4B | 8.2B | 7.9B | 7.6B | 6.7B | 5.9B | 5.8B | 5.8B | 5B | 8.5B | 9.7B | 8.8B | 8.2B | 11.1B | 10.3B | 9.5B | 8.7B | 7.9B | 12.6B | |
-3.8B | -3.6B | -3.7B | -3.2B | -3.2B | -3.3B | -3.3B | -2.9B | -3.5B | -3.3B | -3.3B | -2.2B | -2.1B | -1.9B | -1.5B | -1.8B | -2.4B | -791.2M | -1.4B | -1.7B | |
840M | 915M | 547M | 514M | 626M | -33M | -287M | 629M | -102M | -174M | 729M | 4.9B | 5.3B | 5.5B | 6.2B | 5.4B | 3.9B | 5.2B | 6.1B | 5.6B | |
975M | 1.1B | 700M | 737M | 869M | 194M | -46M | 882M | 117M | 40M | 999M | 5.1B | 5.6B | 5.8B | 6.5B | 5.7B | 4.3B | 5.7B | 6.5B | 6B | |
135M | 153M | 153M | 223M | 243M | 227M | 241M | 253M | 219M | 214M | 270M | 284M | 302M | 280M | 285M | 284M | 404M | 484.1M | 422.6M | 394.5M | |
SUMMARY | ||||||||||||||||||||
16.5B | 17.3B | 18B | 17.8B | 17.5B | 15.3B | 14.5B | 15.2B | 14.6B | 14.8B | 15.5B | 18.9B | 19.9B | 19.4B | 19.9B | 19.2B | 18.1B | 18.4B | 17.1B | 16.3B | |
314M | 306M | 238M | 290M | 300M | 268M | 224M | 233M | 257M | 247M | 257M | 382M | 355M | 338M | 374M | 355M | 0.0 | 390M | 392.9M | 0.0 | |
7.9B | 8.1B | 8.5B | 8.7B | 8.5B | 7.9B | 7.5B | 7.4B | 7.6B | 7.8B | 7B | 5.8B | 6.2B | 6.1B | 5.5B | 5.4B | 6B | 5.5B | 3.6B | 3.8B | |
6.9B | 7B | 8.1B | 8.4B | 8.2B | 7.4B | 6.9B | 6.8B | 6.6B | 7.2B | 6.2B | 4.7B | 5.1B | 5.4B | 4.6B | 4.6B | 5.6B | 5B | 3.2B | 3.5B | |
331,858,421 | 331,858,421 | 331,858,421 | 331,858,421 | 331,858,421 | 331,858,421 | 331,858,421 | 331,858,421 | 331,858,421 | 331,858,421 | 331,858,421 | 331,858,421 | 331,858,421 | 331,858,421 | 331,858,421 | 331,858,421 | 331,858,421 | 331,858,421 | 331,858,421 | 331,858,421 |
KMB - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 14, 2026 | May 14, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 05, 2026 | May 01, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | April 28, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 28, 2026 | April 28, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | March 23, 2026 | December 31, 2025 | 2025 | |
10-K 10-K 2025 FY FY | February 12, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | January 29, 2026 | January 29, 2026 | 2026 | |
8-K 8-K 2026 N/A | January 27, 2026 | January 27, 2026 | 2026 | |
8-K 8-K 2026 N/A | January 16, 2026 | January 16, 2026 | 2026 | |
S-4/A S-4/A (Amended) N/A | December 12, 2025 | December 12, 2025 | ย |
Continue your KMB research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.